Figure S1. PLS-DA was performed on proteomic data. Figure S2. Overlap between proteins detected in CSF of polyarthritis patients at baseline and during infliximab treatment by proteomic profiling (polyarthritis (blue)) and proteins detected in CSF of healthy females (yellow), patients with multiple sclerosis (green) and patients with Alzheimerâs disease or mild cognitive impairment (red) in published studies. (DOCX 483 kb
Stratification of patients based on RF and anti-CCP titers at week 0. (PDF 419 kb
Table S1. Characteristics of the primary antibodies, immunohistochemistry conditions and expression ...
Figure S2. (a) Padi4 gene expression levels in articular tissue samples from pGIA and control mice, ...
Table S1. Proteins significantly altered in CSF of polyarthritis patients after 8 weeks of inflixima...
Background: Signs of inflammation in cerebrospinal fluid (CSF) of rheumatoid arthritis patients corr...
Figure S2. Total protein fluorescent signal from blots used for immunoblot analysis. Total protein l...
Table S2. GO Elite analysis of all 4,133 proteins identified in mouse microglia by TMT mass spectrom...
Methodological approach used to identify NI-0101 responder samples and biomarkers. RA patient strati...
CSF vs. serum IgG2 glycosylation. Afucosylation could only be assessed for IgG1, but not for IgG2, a...
Correlation of ratios of significantly changing proteins shared between TNF and IL-1β groups. (DOCX...
Correlations between platelet activation and markers of inflammation. Correlation between percentage...
Table S1. Log2 transformed protein abundance data and differential expression analyses. (XLSX 1522 k...
Table S2. iTRAQ quantified human brain proteome of AD individuals and their age-matched control with...
Table S2. Accession number (Swiss-Prot) and names of genes coding for proteins identified as over-r...
Representative mass spectrometric IgG1 and IgG2 Fc glycosylation data from an MS patient. Tryptic Fc...
Stratification of patients based on RF and anti-CCP titers at week 0. (PDF 419 kb
Table S1. Characteristics of the primary antibodies, immunohistochemistry conditions and expression ...
Figure S2. (a) Padi4 gene expression levels in articular tissue samples from pGIA and control mice, ...
Table S1. Proteins significantly altered in CSF of polyarthritis patients after 8 weeks of inflixima...
Background: Signs of inflammation in cerebrospinal fluid (CSF) of rheumatoid arthritis patients corr...
Figure S2. Total protein fluorescent signal from blots used for immunoblot analysis. Total protein l...
Table S2. GO Elite analysis of all 4,133 proteins identified in mouse microglia by TMT mass spectrom...
Methodological approach used to identify NI-0101 responder samples and biomarkers. RA patient strati...
CSF vs. serum IgG2 glycosylation. Afucosylation could only be assessed for IgG1, but not for IgG2, a...
Correlation of ratios of significantly changing proteins shared between TNF and IL-1β groups. (DOCX...
Correlations between platelet activation and markers of inflammation. Correlation between percentage...
Table S1. Log2 transformed protein abundance data and differential expression analyses. (XLSX 1522 k...
Table S2. iTRAQ quantified human brain proteome of AD individuals and their age-matched control with...
Table S2. Accession number (Swiss-Prot) and names of genes coding for proteins identified as over-r...
Representative mass spectrometric IgG1 and IgG2 Fc glycosylation data from an MS patient. Tryptic Fc...
Stratification of patients based on RF and anti-CCP titers at week 0. (PDF 419 kb
Table S1. Characteristics of the primary antibodies, immunohistochemistry conditions and expression ...
Figure S2. (a) Padi4 gene expression levels in articular tissue samples from pGIA and control mice, ...